ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $15,067,000 | -63.6% | 798,873 | -77.3% | 0.37% | -58.1% |
Q2 2019 | $41,405,000 | -4.8% | 3,517,856 | +10.4% | 0.87% | -15.0% |
Q1 2019 | $43,488,000 | +50.5% | 3,185,983 | +13.0% | 1.03% | +49.6% |
Q4 2018 | $28,892,000 | -9.4% | 2,818,788 | +47.2% | 0.69% | -4.7% |
Q3 2018 | $31,879,000 | +23.4% | 1,914,690 | +17.1% | 0.72% | +19.4% |
Q2 2018 | $25,834,000 | +261.3% | 1,635,035 | +190.4% | 0.60% | +284.7% |
Q1 2018 | $7,151,000 | +89.8% | 563,037 | +210.8% | 0.16% | +80.5% |
Q1 2017 | $3,768,000 | +0.6% | 181,143 | +0.6% | 0.09% | +2.4% |
Q4 2016 | $3,744,000 | – | 180,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |